Literature DB >> 17050590

Engineering mammalian cytochrome P450 2B1 by directed evolution for enhanced catalytic tolerance to temperature and dimethyl sulfoxide.

Santosh Kumar1, Ling Sun, Hong Liu, B K Muralidhara, James R Halpert.   

Abstract

The previously laboratory-evolved cytochrome P450 2B1 quadruple mutant V183L/F202L/L209A/S334P (QM), which showed enhanced H(2)O(2)-mediated substrate oxidation, has now been shown to exhibit a >3.0-fold decrease in K(m,HOOH) for 7-ethoxy-4-trifluoromethylcoumarin (7-EFC) O-deethylation compared with the parental enzyme L209A. Subsequently, a streamlined random mutagenesis and a high-throughput screening method were developed using QM to screen and select mutants with enhanced tolerance of catalytic activity to temperature and dimethyl sulfoxide (DMSO). Upon screening >3000 colonies, we identified QM/L295H and QM/K236I/D257N with enhanced catalytic tolerance to temperature and DMSO. QM/L295H exhibited higher activity than QM at a broad range of temperatures (35-55 degrees C) and maintained approximately 1.4-fold higher activity than QM at 45 degrees C for 6 h. In addition, QM/L295H showed a significant increase in T(m,app) compared with L209A. QM/L295H and QM/K236I/D257N exhibited higher activity than QM at a broad range of DMSO concentrations (2.5-15%). Furthermore, QM/K236I/D257N/L295H was constructed by combining QM/K236I/D257N with L295H using site-directed mutagenesis and exhibited a >2-fold higher activity than QM at nearly the entire range of DMSO concentrations. In conclusion, in addition to engineering mammalian cytochromes P450 for enhanced activity, directed evolution can also be used to optimize catalytic tolerance to temperature and organic solvent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050590     DOI: 10.1093/protein/gzl042

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  11 in total

1.  Re-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamide.

Authors:  Ling Sun; Chong S Chen; David J Waxman; Hong Liu; James R Halpert; Santosh Kumar
Journal:  Arch Biochem Biophys       Date:  2007-01-08       Impact factor: 4.013

2.  Investigation by site-directed mutagenesis of the role of cytochrome P450 2B4 non-active-site residues in protein-ligand interactions based on crystal structures of the ligand-bound enzyme.

Authors:  P Ross Wilderman; Sean C Gay; Hyun-Hee Jang; Qinghai Zhang; C David Stout; James R Halpert
Journal:  FEBS J       Date:  2011-11-25       Impact factor: 5.542

Review 3.  Plasticity of CYP2B enzymes: structural and solution biophysical methods.

Authors:  P Ross Wilderman; James R Halpert
Journal:  Curr Drug Metab       Date:  2012-02       Impact factor: 3.731

4.  The role of Ile476 in the structural stability and substrate binding of human cytochrome P450 2C8.

Authors:  Lu Sun; Zhong-Hua Wang; Feng-Yun Ni; Xiang-Shi Tan; Zhong-Xian Huang
Journal:  Protein J       Date:  2010-01       Impact factor: 2.371

5.  Rational engineering of cytochromes P450 2B6 and 2B11 for enhanced stability: Insights into structural importance of residue 334.

Authors:  Jyothi C Talakad; P Ross Wilderman; Dmitri R Davydov; Santosh Kumar; James R Halpert
Journal:  Arch Biochem Biophys       Date:  2009-11-26       Impact factor: 4.013

6.  Identification and analysis of conserved sequence motifs in cytochrome P450 family 2. Functional and structural role of a motif 187RFDYKD192 in CYP2B enzymes.

Authors:  Numan Oezguen; Santosh Kumar; Aditya Hindupur; Werner Braun; B K Muralidhara; James R Halpert
Journal:  J Biol Chem       Date:  2008-05-21       Impact factor: 5.157

Review 7.  Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.

Authors:  Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-02       Impact factor: 4.481

8.  The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity.

Authors:  Chiung-Kuang J Chen; Tatiana Kh Shokhireva; Robert E Berry; Hongjun Zhang; F Ann Walker
Journal:  J Biol Inorg Chem       Date:  2008-04-08       Impact factor: 3.358

9.  Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7.

Authors:  Chiung-Kuang J Chen; Robert E Berry; Tatjana Kh Shokhireva; Marat B Murataliev; Hongjung Zhang; F Ann Walker
Journal:  J Biol Inorg Chem       Date:  2009-08-30       Impact factor: 3.358

10.  Dynamics and flexibility of human aromatase probed by FTIR and time resolved fluorescence spectroscopy.

Authors:  Giovanna Di Nardo; Maximilian Breitner; Sheila J Sadeghi; Silvia Castrignanò; Giampiero Mei; Almerinda Di Venere; Eleonora Nicolai; Paola Allegra; Gianfranco Gilardi
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.